Jay Carlson
Chair of the Board - Mercy Clinical Director, Cancer Care Performance Acceleration · Mercy Hospital
Credentials: · · · ·
History
PresentCancer Care Performance Acceleration Department · Mercy Hospital
- 1993–1996
Gynecologic Oncology
- 1989–1993
Obstetrics and Gynecology
Texas Clg Of Osteopathic Med Fort Worth
Research
Prognostic factors for stage III epithelial ovarian cancer: a Gynecologic Oncology Group Study
Journal of Clinical Oncology · 2007 · 688 citations
2001 consensus guidelines for the management of women with cervical intraepithelial neoplasia
Review · American Journal of Obstetrics and Gynecology · 2003 · 217 citations
Gynecologic Oncology · 2018 · 118 citations
- LT
21 papers
- LC
20 papers
17 papers · 11 as a fellow
11 papers
- WW
10 papers
- AS
8 papers · 8 as a fellow
8 papers · 8 as a resident
- GM
8 papers · 4 as a fellow
Grants
- 2014–2027
Ozark Health Ventures LLC Dba Cancer Research for the Ozarks (CRO)
National Cancer Institute · UG1
Contact PI · $14.2M · Ozark Health Ventures, Llc
- 1987–2014
Ozark Health Ventures, LLC Dba Cancer Research for the Ozarks
National Cancer Institute · U10
Contact PI · $780.3K · Ozark Health Ventures, Llc
Clinical trials
- 2012–2020
Principal investigator · Completed · Phase 2
Gynecologic Oncology Group
- 2003
Study chair · Completed · Phase 3
Gynecologic Oncology Group
- 2027–2029
Site PI · Recruiting · Phase 2
National Cancer Institute (NCI)
- 2026–2040
Site PI · Recruiting · Phase 3
Alliance for Clinical Trials in Oncology